title: The low molecular weight (LMW) isoforms of cyclin E deregulate the cell cycle of mammary epithelial cells.
abstract: Cyclin E in complex with CDK2 is a positive regulator of the G1 to S phase transition of the cell cycle and is responsible for cells passing the restriction point, committing the cell to another round of cell division. Cyclin E is overexpressed and proteolytically cleaved into low molecular weight (LMW) isoforms in breast cancer cell lines and tumor tissues compared to normal cells and tissues. These alterations in cyclin E are linked to poor prognosis in breast cancer patients. In order to evaluate the biological effects of the LMW cyclin E, immortalized mammary epithelial cells, 76NE6, were stably transfected with each of the three cyclin E constructs. Our results reveal that the LMW forms of cyclin E (T1 and T2) are biologically functional, as their overexpression in the immortalized cells increases the ability of these cells to enter S and G2/M phase by 2 fold over full length or vector-alone transfected cells, concomitant with an increased rate of cell proliferation. In addition, these LMW isoforms are biochemically hyperactive, shown by their ability to phosphorylate substrates such as histone H1 4 fold more in cells transfected with T1 or T2 versus cells transfected with the full length form. These results suggest that overexpression of the LMW forms of cyclin E is mitogenic, stimulating the cells to progress through the cell cycle much more efficiently than the full length cyclin E.
authors.affiliation: Department of Experimental Radiation Oncology, UT MD Anderson Cancer Center, Houston, Texas 77030-4095, USA.
authors.forename: Hannah
authors.initials: H
authors.lastname: Wingate
authors.forename: Isabelle
authors.initials: I
authors.lastname: Bedrosian
authors.forename: Said
authors.initials: S
authors.lastname: Akli
authors.forename: Khandan
authors.initials: K
authors.lastname: Keyomarsi
mesh_terms: D017398:Alternative Splicing / Q000235:genetics / Q000502:physiology; D000818:Animals; D001943:Breast Neoplasms / Q000378:metabolism; D042846:CDC2-CDC28 Kinases / Q000378:metabolism; D002453:Cell Cycle / Q000502:physiology*; D003001:Cloning, Molecular; D019927:Cyclin E / Q000235:genetics / Q000378:metabolism*; D051357:Cyclin-Dependent Kinase 2; D016193:G1 Phase / Q000502:physiology; D006657:Histones / Q000378:metabolism; D006801:Humans; D008840:Microfilament Proteins / Q000378:metabolism; D009124:Muscle Proteins; D010766:Phosphorylation; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D016196:S Phase / Q000502:physiology; D014407:Tumor Cells, Cultured
chemical_list: D019927:Cyclin E; D006657:Histones; D008840:Microfilament Proteins; D009124:Muscle Proteins; D020033:Protein Isoforms; C058992:Tagln protein, mouse; D042846:CDC2-CDC28 Kinases; C495894:CDK2 protein, human; D051357:Cyclin-Dependent Kinase 2